21 Cited authorities

  1. Ashcroft v. Iqbal

    556 U.S. 662 (2009)   Cited 251,689 times   279 Legal Analyses
    Holding that a claim is plausible where a plaintiff's allegations enable the court to draw a "reasonable inference" the defendant is liable
  2. Bell Atl. Corp. v. Twombly

    550 U.S. 544 (2007)   Cited 265,662 times   364 Legal Analyses
    Holding that a complaint's allegations should "contain sufficient factual matter, accepted as true, to 'state a claim to relief that is plausible on its face' "
  3. Funk v. Stryker Corp.

    631 F.3d 777 (5th Cir. 2011)   Cited 844 times   1 Legal Analyses
    Holding court lacked jurisdiction to consider district court's denial of plaintiff's postjudgment motions because he did not file an amended, or separate, notice of appeal
  4. Chavez v. United States

    683 F.3d 1102 (9th Cir. 2012)   Cited 744 times   1 Legal Analyses
    Holding that a Bivens action could be sustained against Border Patrol agents
  5. Sateriale v. R.J. Reynolds Tobacco Co.

    697 F.3d 777 (9th Cir. 2012)   Cited 187 times   1 Legal Analyses
    Holding that because the plaintiffs' UCL and CLRA claims sounded in fraud, they had to prove reliance
  6. United States ex rel. Modglin v. Djo Global Inc.

    48 F. Supp. 3d 1362 (C.D. Cal. 2014)   Cited 71 times   1 Legal Analyses
    Finding the court could take judicial notice of documents from the Food and Drug Administration's website
  7. Gustavson v. Wrigley Sales Co.

    961 F. Supp. 2d 1100 (N.D. Cal. 2013)   Cited 50 times
    Holding the phrase "flavanols [are] found in cocoa" as characterizing the level of flavanols
  8. Eidson v. Medtronic, Inc.

    981 F. Supp. 2d 868 (N.D. Cal. 2013)   Cited 46 times   1 Legal Analyses
    Holding that claim for loss of consortium is subject to the two-year statute of limitations in Cal. Civ. Proc. Code § 335.1
  9. Erickson v. Boston Scientific Corp.

    846 F. Supp. 2d 1085 (C.D. Cal. 2011)   Cited 43 times
    Granting request for judicial notice of FDA's Premarket Approval documents for defendants' pacemaker product
  10. Funk v. Stryker Corp.

    673 F. Supp. 2d 522 (S.D. Tex. 2009)   Cited 31 times
    Holding that a medical device “could have failed for a variety of reasons and therefore its failure did not ‘speak for itself’ and establish the defendants' negligence”
  11. Rule 12 - Defenses and Objections: When and How Presented; Motion for Judgment on the Pleadings; Consolidating Motions; Waiving Defenses; Pretrial Hearing

    Fed. R. Civ. P. 12   Cited 344,767 times   920 Legal Analyses
    Granting the court discretion to exclude matters outside the pleadings presented to the court in defense of a motion to dismiss
  12. Rule 8 - General Rules of Pleading

    Fed. R. Civ. P. 8   Cited 155,637 times   193 Legal Analyses
    Holding that "[e]very defense to a claim for relief in any pleading must be asserted in the responsive pleading. . . ."
  13. Rule 9 - Pleading Special Matters

    Fed. R. Civ. P. 9   Cited 38,845 times   316 Legal Analyses
    Permitting "[m]alice, intent, knowledge, and other conditions of a person's mind [to] be alleged generally"
  14. Rule 201 - Judicial Notice of Adjudicative Facts

    Fed. R. Evid. 201   Cited 28,180 times   26 Legal Analyses
    Holding "[n]ormally, in deciding a motion to dismiss for failure to state a claim, courts must limit their inquiry to the facts stated in the complaint and the documents either attached to or incorporated in the complaint. However, courts may also consider matters of which they may take judicial notice."
  15. Section 355 - New drugs

    21 U.S.C. § 355   Cited 2,241 times   334 Legal Analyses
    Granting the court discretion to change the date on which an ANDA may be approved if "either party to the action failed to reasonably cooperate in expediting the action"
  16. Section 321 - Definitions; generally

    21 U.S.C. § 321   Cited 1,165 times   158 Legal Analyses
    Defining “new drug”